Stem Cell Clinical Trial
Official title:
Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Paranteral Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Randomized Controlled Study
The goal of this research study is to learn if feeding someone after a stem cell transplant is safe and practical.
Primary Objective: a. To determine feasibility of administering enteral nutrition (EN) via NG/GT in SCT population in peri-transplant period. Secondary Objectives: 1. Determine the differential effects of enteral feeding versus Parenteral feeding on nutrition, and quality of life. 2. Determine the differential effects of enteral feeding versus parenteral feeding on survival and, medical comorbidities 3. Determine the differential effects of enteral feeding versus parenteral feeding on Fitbit data study for patients co-enrolled in Pediatric Energy Balance Data Repository Protocol PA18-0130. 4. Identify differential effects on microbiome for patients co-enrolled on "A Study to Collect Peripheral Blood, Tissue, and Bone Marrow samples from Donors and Recipients of blood and marrow transplants for Laboratory Research Protocol Lab99-062". 5. Determine adverse effects of enteral feeding in this population ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03947450 -
Autologous Volar Fibroblast Injection Into the Stump Site of Amputees
|
Phase 2 | |
| Completed |
NCT05887804 -
Comparison of Keloid Volume and Symptoms Reduction Between Intralesional Umbilical-Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide Injection as Keloid Therapy: A Randomised Controlled Trial
|
Phase 4 | |
| Completed |
NCT05939817 -
The Effect of Intralesian Injection of Umbilical Cord Mesenchymal Stem Cells, Its Conditioned Medium, and Triamcinolone Acetonide on Type 1:3 Collagen Ratio and Interleukin-10 Levels in Keloid: A Randomised Controlled Trial
|
Phase 4 | |
| Completed |
NCT04641533 -
Effect of Dental Pulp Stem Cells and L-PRF After Impacted Third Molar Extraction
|
N/A | |
| Recruiting |
NCT04313894 -
WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS
|
Phase 2 |